Performance of American Society for Gastrointestinal Endoscopy guidelines for dyspepsia in Saudi population: Prospective observational study

Table 2 Clinical characteristics of patients stratified by presence and absence of the normal and abnormal endoscopic finding as well as univariable analysis of all corresponding variables

Characteristics	Percentage of patients	Normal	Abnormal	P value	Univariable analysis
					OR (95%CI)
Female	70.1%	53%	47%	0.399	0.7 (0.37-1.47)
Male	29.9%	45%	55%	0.711	1.02 (0.97-1.56)
Age ≥ 50	29%	60%	40%	0.094	1.01 (0.99-1.04)
Smoker	12%	42%	58%	0.671	1.49 (0.56-3.94)
Taking NSAID	14%	35%	65%	0.094	2.16 (0.86-5.44)
Vomiting	18%	47%	53%	0.285	1.25 (0.54-2.91)
Prior endoscopy	29%	38%	62%	0.039	2.06 (1.02-4.13)
Weight loss	16%	46%	54%	0.283	1.2 5(0.54-2.91)
Loss of appetite	16%	46%	54%	0.283	1.25 (0.54-2.91)
Dysphagia	3%	20%	80%	0.161	4.32 (0.47-39.52)
GI bleeding	3%	20%	80%	0.161	4.32 (0.47-39.52)
Epigastric mass	2%	0%	100%	0.075
Low Hb	39%	41%	59%	0.245	1.08 (0.94-1.25)
Presence of H. pylori	22%	36%	64%	0.044	2.2 (1.01-4.87)

H. pylori: Heliobacter pylori; GI: Gastrointestinal; NSAID: Non-steroidal anti-inflammatory medications.